One year survival of HIV-infected veterans with CD4 < 100 cells/mm³: data from a veteran cohort

References

• Antiretroviral Therapy Cohort Collaboration 2007 . Importance of baseline prognostic factors with increasing time since the initiation of highly active antiretroviral therapy: Collaborative analysis of cohorts in HIV-1-infected patients . Journal of Acquired Immune Deficiency Syndromes , 46 5 , 607 615 .
   PubMed Web of Science ®Google Scholar
• Backus , L.I. , Phillips , B.R. , Boothroyd , D.B. , Mole , L.A. , Burgess , J. Rigsby , M.O. 2005 . Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy . Journal of Acquired Immune Deficiency Syndromes , 39 ( 5 ) : 613 – 619 .
   PubMed Web of Science ®Google Scholar
• Bartlett , J.A. , Fath , M.J. , Demasi , R. , Hermes , A. , Quinn , J. Mondou , E. 2006 . An updated systematic overview of triple combination therapy in antiretroviral-naïve HIV-infected adults . AIDS , 20 ( 16 ) : 2051 – 2064 .
   PubMed Web of Science ®Google Scholar
• Bhavan , K.P. , Kampalath , V.N. and Overton , E.T. 2008 . The aging of the HIV epidemic . Current HIV/AIDS Reports , 5 ( 3 ) : 150 – 158 .
   PubMedGoogle Scholar
• Braithwaite , R.S. , Justice , A.C. , Chang , C.C. , Fusco , J.S. , Raffanti , S.R. Wong , J.B. 2005 . Estimating the proportion of patients infected with HIV who will die of comorbid diseases . American Journal of Medicine , 118 ( 8 ) : 890 – 898 .
   PubMed Web of Science ®Google Scholar
• Braithwaite , R.S. , Kozal , M.J. , Chang , C.C. , Roberts , M.S. , Fultz , S.L. Goetz , M.B. 2007 . Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies . AIDS , 21 ( 12 ) : 1579 – 1589 .
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . 2009a . Morbidity and Mortality Weekly Report: Late HIV Testing-34 States, 1996–2005 . Retrieved September 1, 2009, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5824a2.htm .
   Google Scholar
• Centers for Disease Control and Prevention . 2009b . HIV/AIDS Surveillance Report: Cases of HIV Infection and AIDS in the United States and Dependent Areas, 2007 . Retrieved September 1, 2009, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/ .
   Google Scholar
• Crum , N.F. , Riffenburgh , R.H. , Wegner , S. , Agan , B.K. , Tasker , S.A. Spooner , K.M. 2006 . Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras . Journal of Acquired Immune Deficiency Syndromes , 41 ( 2 ) : 194 – 200 .
   PubMed Web of Science ®Google Scholar
• Deayton , J.R. , Sabin , C.A. , Johnson , M.A. , Emery , V.C. , Wilson , P. and Griffiths , P.D. 2004 . Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy . Lancet , 363 ( 9427 ) : 2116 – 2121 .
   PubMed Web of Science ®Google Scholar
• Dorrucci , M. , Valdarchi , C. , Suligoi , B. , Zaccarelli , M. , Sinicco , A. Giuliani , M. 2004 . The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy . AIDS , 18 ( 17 ) : 2313 – 2318 .
   PubMed Web of Science ®Google Scholar
• Effros , R.B. , Fletcher , C.V. , Gebo , K. , Halter , J.B. , Hazzard , W.R. Horne , F.M. 2008 . Aging and infectious diseases: Workshop on HIV infection and aging: What is known and future research directions . Clinical Infectious Diseases , 47 ( 4 ) : 542 – 553 .
   PubMed Web of Science ®Google Scholar
• Egger , M. , May , M. , Chêne , G. , Phillips , A.N. , Ledergerber , B. Dabis , F. 2002 . Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies . Lancet , 360 ( 9327 ) : 119 – 129 .
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration 2007 . US Department of Health and Human Services Office of Special Health Issues: Information for patients . Drugs used in the treatment of HIV infection. Retrieved February 2, 2008, from http://www.fda.gov/oashi/aids/virals.html .
   Google Scholar
• Gandhi , N.R. , Skanderson , M. , Gordon , K.S. , Concato , J. and Justice , A.C. 2007 . Delayed presentation for human immunodeficiency virus (HIV) care among veterans: A problem of access or screening? . Medical Care , 45 ( 11 ) : 1105 – 1109 .
   PubMed Web of Science ®Google Scholar
• Giordano , T.P. , Gifford , A.L. , White , A.C. Jr , Suarez-Almazor , M.E. , Rabeneck , L. Hartman , C . 2007 . Retention in care: A challenge to survival with HIV infection . Clinical Infectious Diseases , 44 ( 11 ) : 1493 – 1499 .
   PubMed Web of Science ®Google Scholar
• Graviss , E.A. , Breaux , K. , & Minihan , J.L. 1999 . Survival of patients with HIV infections and CD4's below 100 cells/mm3; a nine year follow-up study [Abstract] . 39th interscience conference on antimicrobial agents and chemotherapy 452 . Washington , DC : American Society for Microbiology .
   Google Scholar
• Hoang , T. , Goetz , M.B. , Yano , E.M. , Rossman , B. , Anaya , H.D. Kanapp , H. 2009 . The impact of integrated HIV care on patient health outcomes . Medical Care , 47 ( 5 ) : 560 – 567 .
   PubMed Web of Science ®Google Scholar
• Hooshyar , D. , Hanson , D.L. , Wolfe , M. , Selik , R.M. , Bushkin , S.E. and McNaghten , A.D. 2007 . Trends in perimortal conditions and mortality rates among HIV-infected patients . AIDS , 21 ( 15 ) : 2093 – 2100 .
   PubMed Web of Science ®Google Scholar
• Hosmer , D.W. and Lemeshow , S. 1989 . Applied logistic regression , Somerse , NJ : John Wiley .
   Google Scholar
• Justice , A.C. , Dombrowski , E. , Conigliaro , J. , Fultz , S.L. , Gibson , D. Madenwald , T. 2006a . Veterans aging cohort study (VACS) overview and description . Medical Care , 44 ( Suppl. 2 ) : 13 – 24 .
   Web of Science ®Google Scholar
• Justice , A.C. , Erdos , J. , Brandt , C. , Conigliaro , J. , Tierney , W. and Bryant , K. 2006b . The veterans affairs healthcare system. A unique laboratory for observational and interventional research . Medical Care , 44 ( Suppl. 2 ) : 7 – 12 .
   Web of Science ®Google Scholar
• Kilbourne , A.M. , Justice , A.C. , Rabeneck , L. , Rodriguez-Barradas , M. and Weissman , S. 2001 . General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era . Journal of Clinical Epidemiology , 54 ( S1 ) : 22 – 28 .
   Web of Science ®Google Scholar
• Manfredi , R. 2002 . HIV disease and advanced age: An increasing therapeutic challenge . Drugs & Aging , 19 ( 9 ) : 647 – 669 .
   PubMed Web of Science ®Google Scholar
• Monforte , D.A. , Abrams , D. , Pradier , C. , Weber , R. , Reiss , P. Bonnet , F. 2008 . Data collection on Adverse Events of Anti-HIV Drugs (D:A:D) study group. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies . AIDS , 22 ( 16 ) : 2143 – 2145 .
   PubMed Web of Science ®Google Scholar
• Moore , R.D. , Keruly , J.C. , Gebo , K.A. and Lucas , G.M. 2005 . An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002 . Journal of Acquired Immune Deficiency Syndromes , 39 ( 2 ) : 195 – 198 .
   PubMed Web of Science ®Google Scholar
• Nguyen , N. and Holodniy , M. 2008 . HIV infection in the elderly . Clinical Interventions in Aging , 3 ( 3 ) : 453 – 472 .
   PubMed Web of Science ®Google Scholar
• Palella , F.J. Jr , Baker , R.K. , Moorman , A.C. , Chmiel , J.S. , Wood , K.C. Brooks , J.T. Jr . 2006 . Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study . Journal of Acquired Immune Deficiency Syndromes , 43 ( 1 ) : 27 – 34 .
   PubMed Web of Science ®Google Scholar
• Sackoff , J.E. , Hanna , D.B. , Pfeiffer , M.R. and Torian , L.V. 2006 . Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City . Annals of Internal Medicine , 145 ( 6 ) : 397 – 406 .
   PubMed Web of Science ®Google Scholar
• Schwarz , S. , Hsu , L. , Dilley , J.W. , Loeb , L. and Boyd , S. 2006 . Late diagnosis of HIV infection: Trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS . Journal of the Acquired Immunodeficiency Syndrome , 43 ( 4 ) : 491 – 494 .
   PubMed Web of Science ®Google Scholar
• Strategies for Management of Antiretroviral Therapy (SMART) Study Group , El-Sadr , W.M. Lundgren , J.D. , Neaton , J.D. , Gordin , F. , Abrams , D. , et al . 2006 . CD4+ count-guided interruption of antiretroviral treatment . New England Journal of Medicine , 355 22 , 2283 2296 .
   PubMed Web of Science ®Google Scholar
• Weis , N. , Lindhardt , B.O. , Kronborg , G. , Hansen , A.B. , Laursen , A.L. Christensen , P.B. 2006 . Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: A nationwide cohort study . Clinical Infectious Diseases , 42 ( 10 ) : 1481 – 1487 .
   PubMed Web of Science ®Google Scholar